We provided evidence that the LDB1-LMO2 protein complex promotes disease progression in AML cells through techniques such as mass spectrometry, co-immunoprecipitation, and CUT&Tag experiments 11. This evidence concerns the gene LDB1 and acute myeloid leukemia.